Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation.
Yan L, Bui D, Li Y, Rajeevan N, Rowneki M, Berry K, Argraves S, Huang Y, Hynes DM, Cunningham F, Huang GD, Aslan M, Ioannou GN, Bajema KL.
Yan L, et al. Among authors: huang gd, huang y.
Clin Infect Dis. 2024 Sep 26;79(3):643-651. doi: 10.1093/cid/ciae202.
Clin Infect Dis. 2024.
PMID: 38864601